SciELO - Scientific Electronic Library Online

 
vol.77 suppl.2Incidence and clinical features of arrhythmias after surgical treatment of congenital heart diseaseNew antiarrhythmic agents in atrial fibrillation author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Archivos de cardiología de México

On-line version ISSN 1665-1731Print version ISSN 1405-9940

Abstract

RODRIGUEZ CHAVEZ, Laura Leticia. Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation. Arch. Cardiol. Méx. [online]. 2007, vol.77, suppl.2, pp.54-58. ISSN 1665-1731.

Multiple drugs are helpful for rate control in different tachyarrhythmias, in particular atrial fibrillation (AF). Betablockers (βB) and calcium channel blockers have been used as monotherapy or as adjunctive therapy to antiarrhythmics for mantaining an acceptable ventricular rate. In recent years new concepts about auricular remodelation process as a consequence of AF has shown benefits with drugs as angiotensin-renin system blockers (ARSB) like angiotensin conversing enzime inhibitors (ACEI) and angiotensin receptor blockers (ARB). In this article it will be reviewed the benefits of rate control in AF by using βB and calcium channel blockers and also the benefits in atrial remodelation process and the prevention of AF with ARSB drugs.

Keywords : Atrial fibrillation; Betablockers; Calcium channel blockers; Angiotensin receptor blockers.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License